Collegium Pharmaceutical
COLL
COLL
88 hedge funds and large institutions have $363M invested in Collegium Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
24% more funds holding
Funds holding: 71 → 88 (+17)
19% more capital invested
Capital invested by funds: $305M → $363M (+$58M)
69% less call options, than puts
Call options by funds: $238K | Put options by funds: $779K
Holders
88
Holding in Top 10
2
Calls
$238K
Puts
$779K
Top Buyers
| 1 | +$21.8M | |
| 2 | +$15.8M | |
| 3 | +$13.9M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$7.16M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$6.83M |
Top Sellers
| 1 | -$932K | |
| 2 | -$458K | |
| 3 | -$279K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$177K |
| 5 |
TG
TLP Group
Evanston,
Illinois
|
-$164K |